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Life and Death on the Epidermal Edge: New
Transgenic Mouse Model Resembling Graft
Versus Host Disease (GVHD) Conﬁrms
Importance of Location, Location, Location
Since skin covers the body, it serves as a primary physical
barrier protecting us against physical, chemical, and
infectious assaults. In addition, skin contains an abundance
of immunocytes located both within the epidermis and
dermis to provide both innate and adaptive immune
responses should a deleterious agent breech the stratum
corneum, and enter vital tissue sites in skin. The presence
of immunocytes including dendritic antigen presenting cells
that are highly motile in both epidermis (Langerhans cells
(LC)) and dermis (dermal dendritic cells), together with
resident memory T cells (naı¨ve T cells are largely excluded
from peripheral tissue sites), presents a dilemma. On the
one hand, these professional immunocytes are well posi-
tioned to handle foreign invaders, but these same cells may
also trigger and mediate autoimmune reactions to self-
derived peptides or glycolipids generated during the course
of an inflammatory skin response. Given this dilemma, it
should not be surprising that the skin is one of the most
frequent organ sites beset by persistent T cell-mediated
chronic inflammatory diseases thought to reflect autoim-
mune reactions. The precise molecular basis for this
breakdown in immunological tolerance is an area of active
research by immunodermatologists.
In this issue, a team of immunodermatologists led by Dr
Stephen Katz (p 109) characterizes a transgenic mouse
model in which the epidermal keratinocytes are genetically
engineered to express chicken ovalbumin in the basal layer.
When T cells from another transgenic mouse strain that are
engineered to express a T cell receptor uniquely capable of
recognizing ovalbumin are injected intravenously, these
injected T cells move from the circulation and infiltrate the
skin and esophagus. Inflammatory reactions occur at these
sites, but not in other tissues such as liver, lung, intestine,
etc. At least two other important observations were made in
this study. First, the cutaneous inflammation occurred
without requiring any pre-conditioning of skin following
intravenous administration of the T cell clone; and secondly,
if the T cells were injected intradermally, no significant
inflammatory reaction ensued.
The cutaneous reaction occurring in this model re-
sembled GVHD, as the intravenously administered CD8þ
T cells migrated into the skin and triggered a premature
apoptotic response of epidermal keratinocytes. As such,
this new transgenic model may not only contribute to our
understanding of tolerance induction in skin, it may also
shed light on the immunopathogenesis of acute cutaneous
GVHD. GVHD is well worth studying, as it is a major cause
of morbidity and mortality in allogeneic bone marrow trans-
plantation (alloBMT). Mechanisms that decrease or eliminate
GVHD while preserving graft versus tumor effects and
enhancement of immune reconstitution would be a welcome
addition for improving the safety and efficacy of alloBMT.
Returning to the observations made by Katz et al, the
failure of direct intradermally injected CD8þ ovalbumin-
responsive T cells to trigger an immune response, put
together with the fact that identical CD8þ T cells intrave-
nously injected did provoke a prominent cutaneous inflam-
matory reaction, is intriguing. The authors suggest the basis
for this highly divergent response is due to the importance of
epidermal LC that are required to carry the keratinocyte-
derived antigen (ovalbumin) to the regional lymph node.
Presumably the microenvironment in this extracutaneous
location is conducive to activation of the circulating CD8þ T
cells, whereas in non-inflamed skin, these migrating T cells
are not locally activated. Given the availability of other
transgenic mice with reduced or absent epidermal LC, this
hypothesis could be tested. It would also be interesting to
determine if pre-conditioning the mouse skin with the kinds
of preparative regimens used to ablate recipients’ bone
marrow prior to transplantation, such as high-intensity g
irradiation, or chemotherapeutic administration, would create
any danger signals in the skin, and thereby facilitate local
activation of intradermally injected CD8þ T cells.
In any event, there are several informative lessons to be
gleaned from this report, and as any real estate agent or
land developer will tell you, location, location, location often
determines whether a transaction will be successful or not.
From this report, it appears that the location in which the
peptide antigen derived from ovalbumin is presented will
determine if a cutaneous inflammatory reaction will develop.
Signaling Pathways Regulating Cutaneous
Carcinogenesis Reveal Important Roles for
Survival Factors and the Cytokine TNF-a
Epithelial-derived cancers arising in skin represent one of
the most common neoplasms in humans. Thus, consider-
able effort by a wide range of investigators has focused on
defining molecular events that contribute to the emergence
of malignant cells derived from epidermal keratinocytes.
Two important lines of inquiry involve: (1) characterizing the
response of keratinocytes to ultraviolet irradiation because
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of the strong epidemiological links between sun exposure
and development of skin cancer and (2) determining the role
of chronic inflammation in the pathogenesis of skin cancer,
because sustained inflammation has been connected to
cancer development.
In this issue, there are two interesting reports that deal
with each of these topics. Decraene et al (p 207) examine
the apoptotic response of two different squamous carcino-
ma cell lines that carry p53 mutations, and compare these
responses with normal primary human keratinocytes. Since
these investigators, and others, have observed a role for the
survival pathway mediated by AKT activation, they initially
interrogate these cell lines focusing on AKT. In one cell line,
A431, the malignant cells could not phosphorylate a key
amino acid (i.e., T308), and hence the cells were highly
sensitive to apoptotic induction following UV-light exposure.
But the other malignant cell line A253 constitutively
phosphorylated this residue, and these cells were relatively
resistant to UV-light induced apoptosis. Even when the
A431 cells were stimulated with a mitogen (insulin-like
growth factor-1), they could not phosphorylate T308, and
hence failed to acquire a death-defying phenotype. As
previous reports indicated that wild-type p53 could nega-
tively regulate AKT activity, the stable re-expression of wild-
type p53 was examined in both cell lines, but none of the
aforementioned responses appeared to require functional
p53 (although the mutant p53 present in the T cells may act
as a dominant negative for wild-type p53). Since one of the
prevailing dogmas in cutaneous oncology involves a central
role for p53 as a tumor suppressor, reducing cancer
formation by promoting apoptosis of keratinocytes bearing
UV-light induced DNA mutations, the current results
suggest it may be appropriate to re-examine the precise
molecular role for p53 in cutaneous carcinogenesis. Also,
these results suggest therapeutic agents targeting the AKT
kinase pathway may be capable of triggering apoptotic
reactions in malignant cells, although it will be important not
to perturb the homeostatic planned cell death pathway in
adjacent normal keratinocytes.
In the report by van Hogerlinden et al (p 101)
characterization of a transgenic mouse strain is performed
in which the basal layer keratinocytes are genetically
engineered such that the NF-kB signaling pathway is
inhibited, compared with littermate control mice, all of the
transgenic mice with impaired NF-kB activation developed
invasive tumors accompanied by chronic inflammatory cell
infiltration in the skin. While the loss of NF-kB signaling
would have been predicted to produce enhanced keratino-
cyte proliferation, the associated enhanced levels of the
cytokine TNF-a was a bit surprising, since cytokine
production is generally dependent on NF-kB signaling. It
was also surprising that these transgenic mice routinely
develop skin cancers without requiring exposure to UV-light
or chemical initiators to trigger Ras activation or treatment
with tumor promoters. Given the concomitant presence of
chronic inflammation, the authors speculate on the role
of inflammation in the transformation process, particularly
highlighting a role for the cytokine TNF-a. Besides this
report, another report also employing transgenic mice with
abnormal NF-kB signaling (Pasparakis et al, Nature
417:861–866, 2002) observed a chronic inflammatory skin
phenotype (resembling psoriasis), which was dependent on
TNF-a, as crossing these mice with a transgenic strain
lacking TNF receptor I resulted in complete prevention of
the phenotype.
I raise this other report for two reasons. First, the current
authors also indicate in unpublished results that prevention
of skin cancer occurs when their mice are crossed to mice
lacking TNF-receptor I; and second, because psoriasis
appears to represent a TNF-a-dependent chronic inflamma-
tory skin disease, but psoriatic plaques generally fail to
develop into skin cancers. Thus, there appears to be a ‘‘fly
in the ointment’’ as investigators attempt to link chronic
inflammation to development of skin cancer. Indeed, the
current report in this issue points out that the flaky skin
mutant mouse, and other transgenic mice with chronic skin
inflammation, do not develop skin cancer. Clearly, more work
is required to determine if TNF-a-dependent inflammation is
necessary, but not sufficient, for skin cancer development in
either mice or men and if a more precise role for TNF-a in the
inflammatory response that is linked to cancer exists.
Furthermore, with the growing use of a new class of
biological-based therapies which target TNF-a in patients
with psoriatic arthritis, rheumatoid arthritis, inflammatory
bowel disease, and psoriatic skin disease, it should become
obvious fairly quickly if suppressing TNF-a is not only good
for soothing chronic inflammation, but also for reducing or
preventing the development of skin cancer. Initially, many
of us were concerned that blocking TNF-a would reduce
immunosurveillance, and as is seen in immunocompro-
mised transplant patients, there would be increased, rather
than decreased, number of skin cancers. But in light of the
aforementioned results in mice (and only rare clinical reports
in patients) the jury is still out on the precise role for
cutaneous TNF-a-mediated inflammation and skin cancer.
Only clinical vigilance and further experimentation will
provide us with more definitive answers to this critically
important issue that not only impacts chronic inflammation,
but also cancer development and treatment.
Tape Stripping of Human Skin with a
Molecular Twist
In the past, dermatologists and investigative skin biologists
made use of repeated tape stripping of human skin to study
the Koebner phenomenon in patients with psoriasis, and
to study the effect of barrier perturbation on cytokine
cascades initiated by epidermal keratinocytes. Regarding
the pathogenesis of psoriasis, it was observed that in a
subset of patients, if the symptomless or pre-psoriatic skin
was repeatedly tape stripped to remove the most superficial
layer of epidermis (i.e., the stratum corneum responsible for
maintaining the barrier function of skin), then a psoriatic
lesion would be created. Unfortunately, such induction of
psoriatic lesions was not always predictable, which limited
its usefulness as an investigative tool. Nonetheless, the fact
that such minor trauma to the symptomless could trigger
the onset of psoriatic lesions in some patients permitted
delineation of early cellular events, which was helpful to
immunodermatologists in the pioneering days of psoriasis
clinical research.
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The second use of cellophane tape was to determine if
removal of the stratum corneum was necessary and suffi-
cient to trigger cytokine release by epidermal keratinocytes.
These studies revealed in both human and mouse skin that
tape stripping followed by punch biopsies processed for
RT-PCR, or immunostaining, triggered keratinocytes to
rapidly produce primary cytokines such as TNF-a. Prior to
these results, it was widely believed that keratinocytes were
immunologically inert (i.e., sub-served a brick and mortar
function), and only represented targets for inflammatory
cytokines, and not instigators of inflammatory reactions.
But the clear-cut demonstration using the tape stripping
method in vivo refuted this notion, and opened the way for
additional studies demonstrating unequivocally that kerati-
nocytes possessed an impressive array of immunological
attributes including cytokine production, adhesion molecule
expression and co-stimulatory function—even presenting
bacterial-derived superantigens to T lymphocytes.
In this issue, Wong et al return to the use of adhesive
tape by devising a substitute for invasive punch biopsies to
retrieve RNA from skin cells in a non-invasive fashion. While
Vera Morhenn had previously established that tape stripping
20 times could lead to the recovery of sufficient RNA for
mRNA analysis, she and her colleagues in the current re-
port (p 159) extend this line of inquiry by only using four
sequential applications of tape to human skin. They
documented the utility of this elegant approach by
performing a small clinical trial in which skin was pre-
treated with either 1% sodium lauryl sulfate (SLS) or water
(control) under occlusion. Furthermore, they compared
and contrasted the molecular results obtained after four
sequential tape strippings to results obtained following
shave biopsies.
While tape stripping probably reflects molecular events
in the superficial epidermal layers and hair follicles, shave
biopsies sample a deeper and more heterogenous cell
population. Nonetheless, both non-invasive and invasive
sampling procedures yielded enhanced RNA levels for IL-1b
and IL-8 in SLS-mediated irritated skin; although the relative
fold changes varied widely.
Perhaps of greater significance, the investigator deter-
mined that low RNA yields from the non-invasive tape
stripping sampling method could be combined with DNA
microarray analysis to produce gene expression profiles for
normal and irritated skin. Such a comprehensive approach
may pave the way for follow-up studies comparing and
contrasting the molecular profile of irritant contact versus
allergic contact dermatitis responses in human skin. Indeed,
as the practice of molecular medicine evolves, such non-
invasive skin sampling coupled with customized arrays may
permit diagnostic and prognostic evaluations to be per-
formed for a wide variety of benign, inflammatory, and
malignant skin disorders.
While it may be premature to discard our punch biopsies
or light microscopes and install microarray chips in our
clinics and pathology laboratories, a day may come when
we look into our microscopes and not only see cellular
arrays, but also molecular profiles. Whether we look for
these molecular patterns, or whether we see molecular
patterns may depend on our perspectives and imagina-
tions, rather than limitations in the use of this amazing
technological advancement.
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